march 19th tirzepatide FDA confirms shortage is still over, gives compounders a grace period tirzepatide march 19th IMPORTANT GLP-1

Discuss options with your prescribing provider and compounding pharmacy to determine which formulation aligns with your health goals

Consumers are demanding safer, physician-supervised options as awareness grows around side effects and long-term costs

Dulaglutide itself has a small but real signal for elevated liver enzymes in post-marketing surveillance

The Bottom Line GLP-1s and ADHD meds can work safely togetherbut they require planning and monitoring

However, in a retrospective study of nearly half a million patients, semaglutide was associated with lower risk for incident (HR = 0.27) and recurrent (HR = 0.44) suicidal ideation compared with non-GLP-1 anti-obesity medications